← back to search

Nigel Stallard

University of Warwick · GB
Area of research
Statistics and Probability · Management Science and Operations Research
Research interest
Research interests include Statistical Methods in Clinical Trials, Optimal Experimental Design Methods, Health Systems, Economic Evaluations, Quality of Life, and Advanced Causal Inference Techniques.
h-index
52
citations
9,506
works
345
NIH funding
primary concept
Medicine
email

Recent publications

Group‐Sequential Designs With an Externally‐Driven Change of Primary Endpoint
Statistics in Medicine 2025cited by 0position: lastdoi
Group sequential designs for clinical trials when the maximum sample size is uncertain
Statistics in Medicine 2024cited by 0position: lastdoi
Coping with Information Loss and the Use of Auxiliary Sources of Data: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions
Statistics in Biopharmaceutical Research 2023cited by 8position: middledoi
Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19
JAMA 2022cited by 409position: middledoi
Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial
The Lancet Neurology 2020cited by 129position: middledoi
RECOVERY- Respiratory Support: Respiratory Strategies for patients with suspected or proven COVID-19 respiratory failure; Continuous Positive Airway Pressure, High-flow Nasal Oxygen, and standard care: A structured summary of a study protocol for a randomised controlled trial
Trials 2020cited by 45position: middledoi
HIV self-testing alone or with additional interventions, including financial incentives, and linkage to care or prevention among male partners of antenatal care clinic attendees in Malawi: An adaptive multi-arm, multi-stage cluster randomised trial
PLoS Medicine 2019cited by 211position: middledoi
Investigating interventions to increase uptake of HIV testing and linkage into care or prevention for male partners of pregnant women in antenatal clinics in Blantyre, Malawi: study protocol for a cluster randomised trial
Trials 2017cited by 28position: middledoi
OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer
Health Technology Assessment 2016cited by 77position: middledoi
Directions for new developments on statistical design and analysis of small population group trials
Orphanet Journal of Rare Diseases 2016cited by 39position: lastdoi
Selecting Breast Cancer Patients for Chemotherapy: The Opening of the UK OPTIMA Trial
Clinical Oncology 2012cited by 40position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

John M.S. Bartlett · Edinburgh Cancer Research2 papers (2012–2016) · 2 papers (2024–2025)Christopher Poole · University of Birmingham2 papers (2012–2016)Sarah E. Pinder · The London College2 papers (2012–2016)David Cameron · Corewell Health2 papers (2012–2016)Robert C. Stein · Cambridge University Hospitals NHS Foundation Trust2 papers (2012–2016)Lori E. Dodd · National Institute of Allergy and Infectious Diseases2 papers (2024–2025)Katherine Fielding · Austin Hospital2 papers (2017–2019)Janet Dunn · University of Warwick2 papers (2012–2016)Luke Hugh-Davies · Cambridge University Hospitals NHS Foundation Trust2 papers (2012–2016)Augustine Choko · University of Liverpool2 papers (2017–2019)Hendramoorthy Maheswaran · Johnson & Johnson (United Kingdom)2 papers (2017–2019)Andreas Makris · Institute of Cancer Research2 papers (2012–2016)Peter Hall · St John's Hospital2 papers (2012–2016)Moses Kumwenda · University of South Carolina2 papers (2017–2019)Thomas Jaki · OTH Regensburg2 papers (2024–2025)Adrienne Morgan · University of Rochester Medical Center2 papers (2012–2016)Peter Horby · University of Oxford2 papers (2024–2025)Aurélia Lépine · London School of Hygiene & Tropical Medicine2 papers (2017–2019)Elizabeth L. Corbett · Faculty of Public Health2 papers (2017–2019)